Abstract

Introduction: In India most diabetic patients are not investigated for anemia until appearance of clinical features of renal involvement. Also   reports on relationship of duration of diabetes on the occurrence of anemia are scarce.  The aims of this study were to compare the occurrence of anemia in diabetics without overt features of renal pathology with non-diabetics and to analyze the effect of duration of diabetes on severity of anemia.

Methods: Total 398 subjects with 205 diabetics (125 males and 80 females)   and   193 (113 males and 80 females) non diabetics with controlled blood glucose, normal urea, creatinine reports, with or without hypertension were included.  Duration of diabetes was noted. Haemoglobin was estimated by cyanmethemoglobin method.

Results: The frequency of occurrence of anemia was 46 % and 52.5 % in diabetic males and females respectively. Hemoglobin levels in males were 12.6 and 13.8 g/dl (p=<0.001) whereas in females 11.6 and 11.9g/dl in diabetics and nondiabetics respectively (p>0.05). The earliest duration of diabetes which could affect hemoglobin significantly was 4 years in males and 8 years in females.

Conclusion: Screening for anemia in diabetics at least after 4 years of diabetes   even without clinical features of renal insufficiency may improve the quality of life and   moderate the progression of microvascular complications.

Key words: Diabetes; Anemia; Duration; Occurrence; India  
 
 
» HTML Fulltext    » PDF Fulltext    » doi: 
Nike Air Force 1nike air maxes shoes for men 2015 full episodes

Current Issue

Volume 13, Issue 1, January-March 2021


The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

 

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here

 


 The  most recent editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: